<p>無論他們的投資風格如何——成長、價值、收入或其他——每個人都喜歡超越市場。然而，在相對較長的時間內做到這一點並不容易。這就是為什麼那些能夠持續做到這一點的對沖基金經理會成為華爾街的大牌。</p>
<p>好消息是，即使是那些沒有被支付來挑選股票的普通投資者也仍然可以超越市場。為了幫助你實現這一目標，讓我們討論兩家可能在 2031 年前提供超出平均回報的公司：<strong>Intuitive Surgical</strong>（ISRG 1.04%）和 <strong>Meta Platforms</strong>（META 0.88%）。</p>
<p><img src="https://imageproxy.pbkrs.com/https://g.foolcdn.com/image//query-dXJsPWh0dHBzOi8vZy5mb29sY2RuLmNvbS9lZGl0b3JpYWwvaW1hZ2VzLzg0ODY2Ni9waHlzaWNpYW5zLWluLWFuLW9wZXJhdGluZy1yb29tLmpwZxZ3PTM4NDAWb3A9cmVzaXpl?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://g.foolcdn.com/image//query-dXJsPWh0dHBzOi8vZy5mb29sY2RuLmNvbS9lZGl0b3JpYWwvaW1hZ2VzLzg0ODY2Ni9waHlzaWNpYW5zLWluLWFuLW9wZXJhdGluZy1yb29tLmpwZxZ3PTM4NDAWb3A9cmVzaXpl"/></p>
<p>圖片來源：Getty Images。</p>
<h2>1. Intuitive Surgical</h2>
<p>公平地説，Intuitive Surgical 在過去 12 個月的表現並不理想。增加的 關税 正在影響其財務結果，而它主導的機器人輔助手術（RAS）細分市場的競爭也在加劇。然而，未來幾年內，有幾個因素可能會推動 Intuitive Surgical 的股票大幅上漲。其中之一是其達芬奇系統最新版本的推出，目前已進入第五代。每一代都比前一代更好，這次也不例外。</p>
<p>最新達芬奇系統的一個關鍵新特性是力反饋技術，使外科醫生在手術過程中能夠更好地感知施加在患者組織上的壓力，從而在必要時進行調整，以避免損傷和創傷。</p>
<p>這可能會為患者帶來更好的結果，這將有助於增加對公司技術的需求，無論是來自醫療服務提供者還是消費者。這個達芬奇系統仍然很新——它是在去年推出的，並且反響良好。不過，我們仍處於這個故事的早期階段。</p>
<p>廣告</p>
<p>另一個推動 Intuitive Surgical 增長的重要因素應該是針對新適應症的批准，這有助於提高其手術量，這是收入增長的重要驅動力。Intuitive Surgical 最近宣佈了其達芬奇系統的三個新批准。</p>
<p>展開</p>
<p><img src="https://imageproxy.pbkrs.com/https://g.foolcdn.com/image//query-dXJsPWh0dHBzOi8vZy5mb29sY2RuLmNvbS9hcnQvY29tcGFueWxvZ29zL21hcmsvSVNSRy5wbmcWdz0xMjgWb3A9cmVzaXpl?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="Intuitive Surgical 股票報價" original-src="https://imageproxy.pbkrs.com/https://g.foolcdn.com/image//query-dXJsPWh0dHBzOi8vZy5mb29sY2RuLmNvbS9hcnQvY29tcGFueWxvZ29zL21hcmsvSVNSRy5wbmcWdz0xMjgWb3A9cmVzaXpl"/></p>
<h2>NASDAQ: ISRG</h2>
<p>Intuitive Surgical</p>
<p>今日變動</p>
<p>(-1.04%) $-5.95</p>
<p>當前價格</p>
<p>$566.68</p>
<h3>關鍵數據點</h3>
<p>市值</p>
<p>$2030 億</p>
<p>日內區間</p>
<p>$566.00 - $573.49</p>
<p>52 周區間</p>
<p>$425.00 - $616.00</p>
<p>成交量</p>
<p>34K</p>
<p>平均成交量</p>
<p>2.1M</p>
<p>毛利率</p>
<p>66.37%</p>
<p>這一切都很好，但公司能否解決其面臨的挑戰？可以，而且這樣做可能會刺激其股票。關税帶來了風險，包括成本增加、利潤下降和利潤率縮小。Intuitive Surgical 可以通過幾種方式來應對這個問題，最顯著的是提高價格。由於其一流的設備，公司受益於 定價權，這些設備已被證明能改善患者結果。</p>
<p>憑藉龐大的已安裝基礎，適度的普遍提價可能會產生顯著影響。如果關税威脅持續存在，我認為 Intuitive Surgical 最終會採取多管齊下的方法來應對，包括利用其定價權。</p>
<p>競爭情況如何？<strong>Medtronic</strong>，一家 醫療設備領導者，最近獲得了美國對其 Hugo 系統在泌尿科手術中的批准，但它可能需要 數年時間 才能對 Intuitive Surgical 構成重大挑戰。</p>
<p>此外，由於 RAS 市場尚未充分滲透，因此有多個贏家的空間。因此，Intuitive Surgical 的前景穩健，可能使其在 2031 年前超越更廣泛的股票。</p>
<h2>2. Meta Platforms</h2>
<p>Meta Platforms 的股票在發佈第三季度財報後最近下跌。其業績相當強勁，但市場越來越擔心 Meta 在 人工智能（AI）上的巨大投資——它計劃投入更多資金——可能不會帶來回報。然而，該公司在 AI 方面的工作迄今為止已經做出了重要貢獻。Meta Platforms 的 AI 驅動算法提升了其網站和應用的參與度，並且該公司基於 AI 的努力自動化了大部分廣告發布過程，收入和收益迅速增長。</p>
<p>Meta Platforms 還有更大的雄心。例如，該公司希望在 2026 年底之前完全自動化廣告活動。考慮到這家科技巨頭擁有超過 30 億的日活躍用户，其努力應該會繼續帶來回報。</p>
<p>展開</p>
<p><img src="https://imageproxy.pbkrs.com/https://g.foolcdn.com/image//query-dXJsPWh0dHBzOi8vZy5mb29sY2RuLmNvbS9hcnQvY29tcGFueWxvZ29zL21hcmsvTUVUQS5wbmcWdz0xMjgWb3A9cmVzaXpl?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="Meta Platforms 股票報價" original-src="https://imageproxy.pbkrs.com/https://g.foolcdn.com/image//query-dXJsPWh0dHBzOi8vZy5mb29sY2RuLmNvbS9hcnQvY29tcGFueWxvZ29zL21hcmsvTUVUQS5wbmcWdz0xMjgWb3A9cmVzaXpl"/></p>
<h2>NASDAQ: META</h2>
<p>Meta Platforms</p>
<p>今日變動</p>
<p>(-0.88%) $-5.86</p>
<p>當前價格</p>
<p>$660.09</p>
<h3>關鍵數據點</h3>
<p>市值</p>
<p>$1.7 萬億</p>
<p>日內區間</p>
<p>$659.44 - $665.00</p>
<p>52 周區間</p>
<p>$479.80 - $796.25</p>
<p>成交量</p>
<p>7.9M</p>
<p>平均成交量</p>
<p>18M</p>
<p>毛利率</p>
<p>82.00%</p>
<p>股息收益率</p>
<p>0.32%</p>
<p>但如果它們無法匹配公司所做的投資水平呢？值得注意的是，這種情況以前發生過。Meta Platforms 之所以獲得現在的名稱，部分是因為它當時專注於構建和貨幣化 元宇宙，這一雄心並沒有如管理層所希望的那樣實現。</p>
<p>面對不斷增加的開支和收入增長放緩，部分原因是其在元宇宙的投資和更廣泛的經濟挑戰，Meta Platforms 能夠控制成本，重新聚焦於其高利潤的廣告業務，並最終成為一家更強大的公司。換句話説，該公司有足夠的靈活性來應對市場擔心在未來幾年內發生的挑戰性局面。</p>
<p>與此同時，其財務業績應保持強勁，推動其股價上漲。這些都是 Meta Platforms 能夠在 2031 年前超越市場的良好理由。</p>

直覺外科

<p>本文討論了兩隻成長股，直覺外科和 Meta Platforms，預計它們將在 2031 年前表現優於市場。儘管面臨近期挑戰，直覺外科憑藉其新推出的達芬奇系統和定價能力，仍有增長潛力。Meta Platforms 雖然在其人工智能投資方面受到審查，但其收入增長強勁，商業模式靈活。兩家公司在未來幾年都有可能實現超出平均水平的回報</p>

<p>Whatever their investing style -- growth, value, income, or other -- everyone loves beating the market. However, doing so over a relatively long period is no easy feat. That's why hedge fund managers who consistently pull it off become big names on Wall Street.</p>
<div class="lb-trans"><p>無論他們的投資風格如何——成長、價值、收入或其他——每個人都喜歡超越市場。然而，在相對較長的時間內做到這一點並不容易。這就是為什麼那些能夠持續做到這一點的對沖基金經理會成為華爾街的大牌。</p>
</div><p>The good news is that even average investors who aren't paid to pick stocks can still beat the market. To help you achieve that, let's discuss two corporations that might deliver above-average returns through 2031: <strong>Intuitive Surgical</strong>( ISRG 1.04%) and <strong>Meta Platforms</strong>( META 0.88%).</p>
<div class="lb-trans"><p>好消息是，即使是那些沒有被支付來挑選股票的普通投資者也仍然可以超越市場。為了幫助你實現這一目標，讓我們討論兩家可能在 2031 年前提供超出平均回報的公司：<strong>Intuitive Surgical</strong>（ISRG 1.04%）和 <strong>Meta Platforms</strong>（META 0.88%）。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://g.foolcdn.com/image//query-b3A9cmVzaXplJnVybD1odHRwczovL2cuZm9vbGNkbi5jb20vZWRpdG9yaWFsL2ltYWdlcy84NDg2NjYvcGh5c2ljaWFucy1pbi1hbi1vcGVyYXRpbmctcm9vbS5qcGcmdz0zODQw" alt="Surgeons performing an operation." original-src="https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F848666%2Fphysicians-in-an-operating-room.jpg&amp;w=3840&amp;op=resize"/></p>
<p>Image source: Getty Images.</p>
<div class="lb-trans"><p>圖片來源：Getty Images。</p>
</div><h2>1. Intuitive Surgical</h2>
<div class="lb-trans"><h2>1. Intuitive Surgical</h2>
</div><p>In fairness, Intuitive Surgical hasn't had a great past 12 months. Increased tariffs are affecting its financial results, and competition in its robotic-assisted surgery (RAS) niche, which it dominates, is intensifying. However, several things could drive Intuitive Surgical's stock much higher in the next few years. One of them is the launch of the newest version of its da Vinci system, which is now in its fifth iteration. Each has been better than the last, and this time is no different.</p>
<div class="lb-trans"><p>公平地説，Intuitive Surgical 在過去 12 個月的表現並不理想。增加的 關税 正在影響其財務結果，而它主導的機器人輔助手術（RAS）細分市場的競爭也在加劇。然而，未來幾年內，有幾個因素可能會推動 Intuitive Surgical 的股票大幅上漲。其中之一是其達芬奇系統最新版本的推出，目前已進入第五代。每一代都比前一代更好，這次也不例外。</p>
</div><p>One key new feature of the latest da Vinci system is Force Feedback Technology, which enables surgeons to have a better sense of the pressure they are exerting on patients' tissue during procedures, allowing them to make adjustments as needed to avoid damage and trauma.</p>
<div class="lb-trans"><p>最新達芬奇系統的一個關鍵新特性是力反饋技術，使外科醫生在手術過程中能夠更好地感知施加在患者組織上的壓力，從而在必要時進行調整，以避免損傷和創傷。</p>
</div><p>This could lead to even better outcomes for patients, something that will help increase demand for the company's technology, both from healthcare providers and consumers. This da Vinci system is still new -- it was only launched last year and has been well-received. We're still in the early innings of this story, though.</p>
<div class="lb-trans"><p>這可能會為患者帶來更好的結果，這將有助於增加對公司技術的需求，無論是來自醫療服務提供者還是消費者。這個達芬奇系統仍然很新——它是在去年推出的，並且反響良好。不過，我們仍處於這個故事的早期階段。</p>
</div><p>Advertisement</p>
<div class="lb-trans"><p>廣告</p>
</div><p>Another important growth driver for Intuitive Surgical should be approvals across newer indications, which help boost its procedure volume, an important driver of revenue growth. Intuitive Surgical recently announced three new approvals for one of its da Vinci systems.</p>
<div class="lb-trans"><p>另一個推動 Intuitive Surgical 增長的重要因素應該是針對新適應症的批准，這有助於提高其手術量，這是收入增長的重要驅動力。Intuitive Surgical 最近宣佈了其達芬奇系統的三個新批准。</p>
</div><p>Expand</p>
<div class="lb-trans"><p>展開</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://g.foolcdn.com/image//query-b3A9cmVzaXplJnVybD1odHRwczovL2cuZm9vbGNkbi5jb20vYXJ0L2NvbXBhbnlsb2dvcy9tYXJrL0lTUkcucG5nJnc9MTI4" alt="Intuitive Surgical Stock Quote" original-src="https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Fart%2Fcompanylogos%2Fmark%2FISRG.png&amp;w=128&amp;op=resize"/></p>
<h2>NASDAQ: ISRG</h2>
<div class="lb-trans"><h2>NASDAQ: ISRG</h2>
</div><p>Intuitive Surgical</p>
<div class="lb-trans"><p>Intuitive Surgical</p>
</div><p>Today's Change</p>
<div class="lb-trans"><p>今日變動</p>
</div><p>(-1.04%) $-5.95</p>
<div class="lb-trans"><p>(-1.04%) $-5.95</p>
</div><p>Current Price</p>
<div class="lb-trans"><p>當前價格</p>
</div><p>$566.68</p>
<div class="lb-trans"><p>$566.68</p>
</div><h3>Key Data Points</h3>
<div class="lb-trans"><h3>關鍵數據點</h3>
</div><p>Market Cap</p>
<div class="lb-trans"><p>市值</p>
</div><p>$203B</p>
<div class="lb-trans"><p>$2030 億</p>
</div><p>Day's Range</p>
<div class="lb-trans"><p>日內區間</p>
</div><p>$566.00 - $573.49</p>
<div class="lb-trans"><p>$566.00 - $573.49</p>
</div><p>52wk Range</p>
<div class="lb-trans"><p>52 周區間</p>
</div><p>$425.00 - $616.00</p>
<div class="lb-trans"><p>$425.00 - $616.00</p>
</div><p>Volume</p>
<div class="lb-trans"><p>成交量</p>
</div><p>34K</p>
<div class="lb-trans"><p>34K</p>
</div><p>Avg Vol</p>
<div class="lb-trans"><p>平均成交量</p>
</div><p>2.1M</p>
<div class="lb-trans"><p>2.1M</p>
</div><p>Gross Margin</p>
<div class="lb-trans"><p>毛利率</p>
</div><p>66.37%</p>
<div class="lb-trans"><p>66.37%</p>
</div><p>That's all well and good, but can the company address its challenges? It can, and doing so may jolt its stock. Tariffs pose dangers, including increased costs, lower profits, and narrower margins. Intuitive Surgical could get around that problem in several ways, most notably by increasing its prices. The company benefits from pricing power due to its best-in-class devices, which have been proven to improve patient outcomes.</p>
<div class="lb-trans"><p>這一切都很好，但公司能否解決其面臨的挑戰？可以，而且這樣做可能會刺激其股票。關税帶來了風險，包括成本增加、利潤下降和利潤率縮小。Intuitive Surgical 可以通過幾種方式來應對這個問題，最顯著的是提高價格。由於其一流的設備，公司受益於 定價權，這些設備已被證明能改善患者結果。</p>
</div><p>With a large installed base, relatively modest price hikes across the board could have a meaningful effect. If the threat of tariffs persists, my view is that Intuitive Surgical will eventually adopt a multipronged approach to addressing it, including leveraging its pricing power.</p>
<div class="lb-trans"><p>憑藉龐大的已安裝基礎，適度的普遍提價可能會產生顯著影響。如果關税威脅持續存在，我認為 Intuitive Surgical 最終會採取多管齊下的方法來應對，包括利用其定價權。</p>
</div><p>What about competition? <strong>Medtronic</strong>, a medical device leader, recently earned approval in the U.S. for its Hugo system in urologic procedures, but it will likely take years before it poses a significant challenge to Intuitive Surgical.</p>
<div class="lb-trans"><p>競爭情況如何？<strong>Medtronic</strong>，一家 醫療設備領導者，最近獲得了美國對其 Hugo 系統在泌尿科手術中的批准，但它可能需要 數年時間 才能對 Intuitive Surgical 構成重大挑戰。</p>
</div><p>Besides, since the RAS market is underpenetrated, there is room for multiple winners. Therefore, Intuitive Surgical's outlook is robust and could enable it to outperform broader equities through 2031.</p>
<div class="lb-trans"><p>此外，由於 RAS 市場尚未充分滲透，因此有多個贏家的空間。因此，Intuitive Surgical 的前景穩健，可能使其在 2031 年前超越更廣泛的股票。</p>
</div><h2>2. Meta Platforms</h2>
<div class="lb-trans"><h2>2. Meta Platforms</h2>
</div><p>Meta Platforms' shares recently dropped after it released its third-quarter earnings. Its results were fairly strong, but the market is increasingly worried that Meta's huge investments in artificial intelligence (AI) -- where it is planning to pour even more funds -- may not pay off. However, the company's work in AI has made meaningful contributions so far. Between Meta Platforms' AI-powered algorithms boosting engagement across its websites and apps, and the company's AI-based efforts to automate much of the ad launch process, revenue and earnings have been growing rapidly.</p>
<div class="lb-trans"><p>Meta Platforms 的股票在發佈第三季度財報後最近下跌。其業績相當強勁，但市場越來越擔心 Meta 在 人工智能（AI）上的巨大投資——它計劃投入更多資金——可能不會帶來回報。然而，該公司在 AI 方面的工作迄今為止已經做出了重要貢獻。Meta Platforms 的 AI 驅動算法提升了其網站和應用的參與度，並且該公司基於 AI 的努力自動化了大部分廣告發布過程，收入和收益迅速增長。</p>
</div><p>Meta Platforms has even bigger ambitions. The company wants to completely automate ad campaigns by the end of 2026, for instance. Given the tech leader's large ecosystem of more than 3 billion daily active users, its efforts should continue paying off.</p>
<div class="lb-trans"><p>Meta Platforms 還有更大的雄心。例如，該公司希望在 2026 年底之前完全自動化廣告活動。考慮到這家科技巨頭擁有超過 30 億的日活躍用户，其努力應該會繼續帶來回報。</p>
</div><p>Expand</p>
<div class="lb-trans"><p>展開</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://g.foolcdn.com/image//query-b3A9cmVzaXplJnVybD1odHRwczovL2cuZm9vbGNkbi5jb20vYXJ0L2NvbXBhbnlsb2dvcy9tYXJrL01FVEEucG5nJnc9MTI4" alt="Meta Platforms Stock Quote" original-src="https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Fart%2Fcompanylogos%2Fmark%2FMETA.png&amp;w=128&amp;op=resize"/></p>
<h2>NASDAQ: META</h2>
<div class="lb-trans"><h2>NASDAQ: META</h2>
</div><p>Meta Platforms</p>
<div class="lb-trans"><p>Meta Platforms</p>
</div><p>Today's Change</p>
<div class="lb-trans"><p>今日變動</p>
</div><p>(-0.88%) $-5.86</p>
<div class="lb-trans"><p>(-0.88%) $-5.86</p>
</div><p>Current Price</p>
<div class="lb-trans"><p>當前價格</p>
</div><p>$660.09</p>
<div class="lb-trans"><p>$660.09</p>
</div><h3>Key Data Points</h3>
<div class="lb-trans"><h3>關鍵數據點</h3>
</div><p>Market Cap</p>
<div class="lb-trans"><p>市值</p>
</div><p>$1.7T</p>
<div class="lb-trans"><p>$1.7 萬億</p>
</div><p>Day's Range</p>
<div class="lb-trans"><p>日內區間</p>
</div><p>$659.44 - $665.00</p>
<div class="lb-trans"><p>$659.44 - $665.00</p>
</div><p>52wk Range</p>
<div class="lb-trans"><p>52 周區間</p>
</div><p>$479.80 - $796.25</p>
<div class="lb-trans"><p>$479.80 - $796.25</p>
</div><p>Volume</p>
<div class="lb-trans"><p>成交量</p>
</div><p>7.9M</p>
<div class="lb-trans"><p>7.9M</p>
</div><p>Avg Vol</p>
<div class="lb-trans"><p>平均成交量</p>
</div><p>18M</p>
<div class="lb-trans"><p>18M</p>
</div><p>Gross Margin</p>
<div class="lb-trans"><p>毛利率</p>
</div><p>82.00%</p>
<div class="lb-trans"><p>82.00%</p>
</div><p>Dividend Yield</p>
<div class="lb-trans"><p>股息收益率</p>
</div><p>0.32%</p>
<div class="lb-trans"><p>0.32%</p>
</div><p>But what if they don't match the level of investments the company is making? It's worth noting that something like this has happened before. Meta Platforms got its current name partly due to its then-focus on building and monetizing the metaverse, an ambition that never quite materialized, at least not anywhere near the level management had hoped.</p>
<div class="lb-trans"><p>但如果它們無法匹配公司所做的投資水平呢？值得注意的是，這種情況以前發生過。Meta Platforms 之所以獲得現在的名稱，部分是因為它當時專注於構建和貨幣化 元宇宙，這一雄心並沒有如管理層所希望的那樣實現。</p>
</div><p>When faced with mounting expenses and declining revenue growth, partly due to its metaverse investments and broader economic challenges, Meta Platforms was able to rein in costs, refocus on its highly profitable advertising business, and ultimately emerge as a stronger company. In other words, the corporation has enough flexibility to handle the kind of challenging situation the market fears will happen in a few years.</p>
<div class="lb-trans"><p>面對不斷增加的開支和收入增長放緩，部分原因是其在元宇宙的投資和更廣泛的經濟挑戰，Meta Platforms 能夠控制成本，重新聚焦於其高利潤的廣告業務，並最終成為一家更強大的公司。換句話説，該公司有足夠的靈活性來應對市場擔心在未來幾年內發生的挑戰性局面。</p>
</div><p>Meanwhile, its financial results should remain robust, driving its stock price higher. These are all good reasons that Meta Platforms can beat the market through 2031.</p>
<div class="lb-trans"><p>與此同時，其財務業績應保持強勁，推動其股價上漲。這些都是 Meta Platforms 能夠在 2031 年前超越市場的良好理由。</p>
</div>

Prediction: These 2 Growth Stocks Will Beat the Market Through 2031

- Intuitive Surgical 和 Meta Platforms 被認為可能在 2031 年實現超額回報。  
- Intuitive Surgical 正面臨關税等挑戰，但新產品和審批將推動增長。  
- Meta Platforms 通過 AI 技術提升廣告收入，有潛力應對市場挑戰。

預測：這兩隻成長型股票將在 2031 年前超越市場表現